Rapid Dantrolene Administration with Body Temperature Monitoring Is Associated with Decreased Mortality in Japanese Malignant Hyperthermia Events

Table 5

Adjusted odds ratios of prognosis associated with the condition at dantrolene administration.

Explanatory variables	Odds ratio	95% CI	value
Temperature at dantrolene administration (°C)	0.04	0.0009-0.57	0.04
Maximum body temperature (°C)	4.22	0.43-54.3	0.21
Interval from first MH sign to dantrolene administration (min)	0.96	0.92-0.99	0.04
Anesthetic induction to first MH sign (min)	1.01	0.99-1.02	0.46

MH: malignant hyperthermia; 95% CI: 95% confidence interval.